Stereotactic radiosurgery for patients with "radioresistant" brain metastases Academic Article Article uri icon

Overview

MeSH Major

  • Brain
  • Nerve Regeneration
  • Neurons
  • Stem Cell Transplantation
  • Stem Cells

abstract

  • Well-selected patients with brain metastases from radioresistant primary tumors who undergo SRS survive longer than historical controls. RPA Class I status and primary renal cell carcinoma predict longer survival. Adjuvant WBRT improves local control and decreases DBF but does not affect overall survival. Further studies are needed to determine which patients should receive WBRT.

publication date

  • September 2002

Research

keywords

  • Academic Article

Identity

Digital Object Identifier (DOI)

  • 10.1097/00006123-200209000-00009

PubMed ID

  • 12188943

Additional Document Info

start page

  • 656

end page

  • 65; discussion 665-7

volume

  • 51

number

  • 3